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Traceless Isoprenylation
Traceless Isoprenylation of Aldehydes via N-Boc-N-(1,1-dimethyl-
allyl)hydrazones
Desirée Heerdegen,[a] Julia Junker,[a] Sebastian Dittrich,[a] Peter Mayer,[b] and
Franz Bracher*[a]
Abstract: A short isoprenylation protocol starting from non-
conjugated N-Boc-N-(1,1-dimethylallyl)hydrazones was devel-
oped utilising Thomson's traceless bond construction. This type
of [3,3]-sigmatropic rearrangement is catalysed by the Brønsted
acid triflimide and liberates only gaseous by-products. The re-
quired N-Boc-N-allylhydrazine precursor is available in three
Introduction
The [3,3]-sigmatropic rearrangement is a common but impress-
ive tool for the formation of new C–C-bonds in synthetic chem-
istry.[1] In 1973 Stevens showed that N-allylhydrazones undergo
such a rearrangement under release of N2 as well, but due to
very harsh reaction conditions (300 °C) and low yields, this reac-
tion was limited in its applicability.[2] For several decades, syn-
thetic chemists did not see any real benefit of this unique rear-
rangement, until 2010, when Thomson and co-workers pub-
lished the traceless bond construction (TBC), an improved vari-
ant of Stevens' [3,3]-sigmatropic rearrangement, working with
N-Boc-N-allylhydrazones (A, Scheme 1a) and catalytic amounts
of the Brønsted superacid triflimide (HNTf2).[3] It was now possi-
ble to lower the temperature of the rearrangement to 125 °C
and the yields of the products could be increased. This pioneer-
ing work of Thomson allowed the synthesis of various 1,2-
disubstituted olefins (B) and one 1,1-disubstituted olefin
(Scheme 1a). Mono-substituted olefins could not be obtained
by this way. Later our group extended the scope to the synthe-
sis of 1,1-disubstituted olefins (D, Scheme 1b), bearing an iso-
propyl group in 1-position, which resulted in a methylene
branched end, a motif which is found in the side chains of
steroidal natural products, e.g. episterol.[4] In the same year we
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steps starting from a known diazene using biocatalytic aldol
addition and Tebbe olefination as key steps. Allylhydrazones are
prepared via condensation with appropriate aldehydes. Scope
and limitations of the [3,3]-sigmatropic rearrangements are ana-
lysed.
reported the synthesis of terminal vinylsilanes (F, Scheme 1c)
using TBC, which opened a new route to diversely substituted
olefins.[5]
Scheme 1. a) Original TBC by Thomson and co-workers.[3] b) Extension of the
TBC to the synthesis of 1,1-disubstituted olefins bearing an isopropyl group.[4]
c) TBC yielding terminal vinylsilanes.[5] d) Introduction of an isoprenyl group
via TBC developed in this work.
In this work we present a protocol for the introduction of an
isopentenyl (isoprenyl) residue to aldehydes (Scheme 1d). The




European Journal of Organic Chemistry
biomolecules and natural secondary metabolites.[6] The natural
isoprene building block in terpenoid biosynthesis is dimethyl-
allyl pyrophosphate (DMAPP).[7,8] Steroids like cholesterol as a
membrane component,[9] pigments like -carotene,[10] or
cortisone or progesterone to name a few hormones,[11] are nat-
urally occurring terpenoid derivatives, derived from DMAPP.
At the biological level, protein prenyltransferases attach
terpenoid residues like farnesyl (C15) or geranylgeranyl (C20)
groups to cysteinyl residues of proteins in posttranslational
modifications. Due to the introduction of this hydrophobic
group, the proteins can anchor in biomembranes resulting in
altered biological activities.[12] In synthetic chemistry, organo-
metallic building blocks like 3-methyl-2-butenylmagnesium
chloride are commonly used for the introduction of an iso-
prenyl group.[13] Utilising inverse reactivities, 3,3-dimethylallyl
bromide can be applied as an electrophilic isoprenyl building
block,[14] as exemplified by the total syntheses of natural prod-
ucts, e.g. (±)-eldanolide[15] and (±)-fumagillin.[16] Besides direct
isoprenylation, eliminations can lead to the isoprenyl function
by forming the thermodynamically most stable double bond,
e.g. from tertiary alcohols by dehydration.[17] An intramolecular
isoprenylation, in which the group is constructed during a rear-
rangement, is to the best of our knowledge, not described in
literature yet.
A further centrepiece of this work is the synthesis of the
required, hitherto unknown, N-Boc-N-(1,1-dimethylallyl)hydraz-
ine building block (G, Scheme 1d), bearing two geminal methyl
groups in α-position to the hydrazine moiety to receive the
desired isoprenylated products (I, Scheme 1d) via N-Boc-N-allyl-
hydrazones (H, Scheme 1d). In our previous investigations lead-
ing to 1,1-disubstituted olefins,[4] undesired subsequent acid-
catalysed isomerisations of the formed olefinic double bond
were observed,[18] which led occasionally to isomeric mixtures
of product alkenes. In the present case this is not expected to
happen, since the resulting trisubstituted olefin should be the
thermodynamically most stable isomer. An additional benefit of
the two geminal methyl groups in precursor G is on the one
hand that product I cannot be formed as mixture of E/Z isomers
and on the other hand it is expected to facilitate the rearrange-
ment due to the Thorpe-Ingold effect (gem-dimethyl effect).[19]
As a result, less drastic reaction temperatures and shortened
reaction times may be employable.[20]
Results and Discussion
The synthesis of the required N-Boc-N-(1,1-dimethylallyl)hydraz-
ine building block 8a (Scheme 2; G in Scheme 1d) started with
the two-step synthesis of known N-Troc-N-Boc-protected di-
azene 2.[21] Conversion into aldehyde 6a was performed on two
different routes. Route A used commercially available silyl enol
ether 3, which was activated by LiOTf and TBAF. The idea was
to achieve a controlled O-Si-bond cleavage in 3 by slow addi-
tion of the fluoride source. Simultaneously, the presence of sig-
nificant amounts of lithium ions should lead to an immediate
formation of the lithium enolate. However, the addition of 3 to
2 did not proceed in a regioselective manner, and a 50:50 mix-
ture of the isomeric aldehydes 6a and its regioisomer 6b was
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obtained. It is noteworthy, that the regioselectivity of this reac-
tion could not be measured in this step, hence, it was deter-
mined retrospectively after conversion into 8a/8b after the last
step. Both isomers showed identical chromatographic behav-
iour and no distinct signals enabling quantification of the ratio
of regioisomers could be observed by NMR spectroscopy until
reaching 8a/8b. Because of the lack of regioselectivity, an alter-
native approach to intermediate 6a utilising organocataly-
sis[22,23] was worked out (route B). For this Aldol-type reaction
with isobutyraldehyde (4), three catalysts were explored: L-
proline,[24] L-phenylalanine,[25] and Ley's (S)-5-(pyrrolidin-2-yl)-
1H-tetrazole (5).[21,26] Tetrazole catalyst 5 gave the best result
with 68 % yield and the isomeric ratio could be improved to
91:9 (determined retrospectively by 1H NMR spectroscopy) of
the desired aldehyde 6a and its regioisomer 6b. Methylenation
of the aldehyde function of 6a/6b gave the olefins 7a and 7b.
Different methods like Wittig,[27] Nysted-Takai[28] and Tebbe[29]
olefination were tested, whereby the first two methods did not
result in any product. Under Tebbe conditions the desired ter-
minal olefin 7a and its regioisomer 7b were obtained in an
acceptable yield of 48 % as an inseparable mixture.
Scheme 2. Route A leading to an equimolar mixture of 8a/8b starting from
silyl enolether 3. Route B provides 8a, contaminated with 9 % of isomer 6b
starting from aldehyde 4. *The ratios of the isomers were determined retro-
spectively by NMR spectroscopy of the product 8a/8b. The X-ray crystal struc-
ture of the desired isomer 8a is shown on the left. Diazene 2 was synthesised
according to literature.[21]
Chemoselective reductive Troc cleavage with zinc powder
gave a still inseparable mixture of the desired olefin 8a and its
constitutional isomer 8b in excellent yield. However, at this
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isomers (route A 50:50, route B 91:9). The structure of the de-
sired N-Boc-N-allylhydrazine 8a was unambiguously confirmed
by X-ray crystal structure analysis (see Supporting Information).
The enriched isomeric mixture of building block 8a and 8b
could be used for the next step without further purification,
since exclusively 8a undergoes condensation with the em-
ployed aldehydes to give the N-Boc-N-allylhydrazones 9,
whereas the isomer 8b remains unreacted. Scheme 3 shows the
prepared allylhydrazones 9a–q. Aliphatic (9a-d, 9f, 9g, 9p), all-
ylic (9h, 9q) and aromatic (9i–9o) and ester-bearing (9e) allyl-
hydrazones were synthesised by reacting the appropriate alde-
hydes with building block mixture 8a/b in ethanol (yields 33–
95 %). Especially non-conjugated allylhydrazones slowly de-
composed during the purification process, which is reflected in
the yields. Before we studied the capability of our N-Boc-N-
allylhydrazine building block 8a, we identified the optimum re-
action conditions for the rearrangement utilising cyclohexane-
carboxaldehyde-derived hydrazone 9g as a model compound.
Overall, 33 test reactions were performed with variations of
temperature (23 to 125 °C), time (15 to 75 min) and solvents
(THF and diglyme) (see Supporting Information). Significant re-
arrangement was only accomplished at temperatures of 75 °C
and above. Besides HNTf2 (pKa –12.0, measured in DCE),[30] triflic
acid (TfOH, pKa –11.3, measured in DCE)[30] and trifluoroacetic
acid (TFA, pKa 0.23)[31] were tested. All in all, the hitherto used
conditions of Thomson[3] (HNTf2, diglyme, 125 °C) gave the best
results for this conversion, closely followed by the rearrange-
ment with triflic acid in diglyme at 125 °C, which would be a
rewarding alternative to HNTf2, which decomposes immediately
in air and requires extremely dry reaction conditions. As the
Scheme 3. N-Boc-N-allylhydrazones 9a–q prepared via condensation reaction
between N-Boc-N-allylhydrazine 8a and appropriate aldehydes. The yields re-
fer to the content of N-Boc-N-allylhydrazine 8a in the applied 8a/8b mixture.
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main side product, and even right at the beginning of the reac-
tion, the corresponding Boc-deprotected allylhydrazone was
observed, a compound which does not undergo the rearrange-
ment. This is in accordance with the observations of Thomson
and could not be prevented.[3] This prompted us to further in-
vestigate an alternative carbamate residue, which might be less
prone to premature acidic cleavage. We prepared the ethyl
carbamate analogue S5a of 8a starting from ethyl carbazate on
a route analogous to route B shown in Scheme 2 (for details,
see Supporting Information). Two N-Boc-N-allylhydrazones S6g
and S6i derived thereof were subjected to the previously deter-
mined best reaction conditions for rearrangement (HNTf2, di-
glyme, 125 °C), but though the starting materials were fully
consumed, none of the expected rearrangement products
could be identified by GC/MS analysis. Consequently, the Boc
group cannot be replaced in this protocol by the smaller eth-
oxycarbonyl group.
Scheme 4 shows the following rearrangement of substrates
9. The allylhydrazones 9a–c derived from n-alkanals underwent
sigmatropic rearrangement providing the appropriate olefins
10a–c in 20–21 % isolated yields. The poor yields are in part
due to the high volatility of the olefinic products, as demon-
strated by an increased yield (25 %) of 10g on a larger scale
(3 mmol). The rearrangement product 10d of isobutyraldehyde-
derived N-allylhydrazone 9d could be detected by GC/MS, but
could not be isolated due to its very high volatility (b.p. 135–
136 °C[32]). Ester 9e did not undergo rearrangement to the cor-
responding olefin and only the Boc-deprotected allylhydrazone
was found.
Scheme 4. Successful rearrangements of N-Boc-N-allyhydrazones using the
standard conditions of the TBC. The reactions were performed at least in a
0.5 mmol scale. Isolated yields are given.
N-Allylhydrazones derived from cycloalkane carboxaldehydes
(9f, 9g) underwent rearrangement to olefins 10f and 10g with
a yield of 20 % for both compounds (Scheme 4). In contrast,
allylhydrazone 9h derived from an α,-unsaturated aldehyde
did not undergo rearrangement and again only Boc-depro-
tected allylhydrazone was isolated. The attempted rearrange-
ments of variously substituted arylidene hydrazones failed as
well (9i–m). During the purification process of the attempted
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which were identified as the symmetric bis-hydrazones 12a/b
(Scheme 5).
Scheme 5. Attempted rearrangements of allylhydrazones 9i and 9j leading
to deprotected allylhydrazons 11a/b and bis-hydrazones 12a/b.
Obviously, acid-mediated removal of both the Boc and the
dimethylallyl residue took place in these experiments. Next to
those, once again Boc-deprotected allylhydrazones 11a/b were
formed. Introduction of both electron-donating (methoxy com-
pound 9l) and electron-withdrawing groups (nitro compound
9m) did not lead to successful rearrangements, and the same
holds for hydrazones derived from heteroaromatic aldehydes
(thiophene 9n and pyridine 9o). After these experiments it be-
came evident which type of allylhydrazones would undergo the
attempted acid-catalysed rearrangement. Non-conjugated allyl-
hydrazones, like aliphatic systems 9a-d, 9f, and 9g form the
corresponding olefins, in contrast to allylhydrazones conjugated
with aryl or ester groups, which do not show any rearrange-
ment. The following experiments supported this assumption:
Non-conjugated N-allylhydrazone 9p derived from phenyl-
propanal showed a successful rearrangement with 19 % yield,
whereas its cinnamaldehyde-derived congener 9q did not give
the desired alkene 10q and only Boc-deprotected allyl-
hydrazone was obtained. Thomson also reported on problems
during the development of methods for hydrazone rearrange-
ments, but with aliphatic systems,[3,33] which resulted in uniden-
tified decomposition products. However, the rearrangement of
aryl-substituted allylhydrazones worked well in his setup. Boc-
deprotected allylhydrazones were observed in every reaction as
by-products by GC/MS analysis, but no rearrangement takes
place with these deprotected forms under our conditions. The
deprotection reaction outcompetes the rearrangement and is a
possible reason for the observed yields. This finding validates
computational studies towards the mechanism of the triflimide-
catalysed [3,3]-sigmatropic rearrangement by Gutierrez et al. in-
dicating that conversion of deprotected allylhydrazones does
not proceed well or not at all.[34]
Conclusion
In summary, we present a unique method for traceless isopren-
ylation of aliphatic aldehydes via triflimide-catalysed [3,3]-
sigmatropic rearrangement of N-Boc-N-allylhydrazones. The
central N-Boc-N-allylhydrazine building block 8a is available in
four steps utilising organocatalysis and Tebbe methylenation.
This method opens a new route to isoprenyl compounds. This
novel protocol is compromised by poor yields in the final step
and its limitation to non-conjugated systems. Nevertheless, it
broadens the scope of Stevens-type traceless bond construc-
tions and represents the first example of a TBC for the introduc-
tion of an isoprenyl group into readily available aliphatic alde-
hydes. Therefore, this work extends the repertoire of methods
for the total synthesis of isoprenoid natural products.
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Experimental Section
General Information: All reactions were carried out in oven-dried
Schlenk flasks equipped with a septum and a magnetic stirring bar
which were evacuated and back filled with dry nitrogen. Solvents
were dried according to standard methods by distillation over dry-
ing agents. Thin layer chromatography (TLC) was performed using
polyester sheets polygram SIL G/UV254 covered with SiO2 (layer
thickness 0.2 mm, 40 × 80 mm) from Macherey-Nagel. Spots were
visualized with a CAM (ceric ammonium molybdate) solution fol-
lowed by heating. Flash column chromatography was performed
using SiO2 60 (0.040–0.063 mm, 230–400 mesh ASTM) from Merck.
For chromatography distilled solvents were used. NMR spectra were
recorded on JNM-Eclipse 400 (400 MHz), JNM-Eclipse 500
(500 MHz), Avance III HD 400 MHz Bruker Biospin (400 MHz) and
Avance III HD 500 MHz Bruker Biospin (500 MHz) with CryoProbe™
Prodigy. Chemical shifts δ are reported as δ values in ppm relative
to the deuterated solvent peak. The chemical shifts are reported in
parts per million [ppm] and refer to the δ scala. Coupling constants
J are indicated in Hertz [Hz]. For the characterization of the ob-
served signal multiplicities the following abbreviations were ap-
plied: s (singlet), d (doublet), dd (doublet of doublet), dt (doublet
of triplet), t (triplet), q (quartet), quint (quintet), m (multiplet), br
(broad). Infrared spectra were recorded from 4000–650 cm–1 on a
PERKIN ELMER Spectrum BX-59343 FT-IR instrument. For detection
a Smiths Detection DuraSamp IR II Diamond ATR sensor was used.
The absorption bands are reported in wave numbers (cm–1). High
resolution mass spectra (HRMS) were recorded on a Jeol Mstation
700 (Fa. Jeol, Peabody, USA) or JMS GCmate II Jeol instrument for
electron impact ionisation (EI) equipped with a quadrupole doublet
based lens system. Thermo Finnigan LTQ FT (Fa. Thermo Electron
Corporation, Bremen, Germany) was used for electrospray ioniza-
tion (ESI) equipped with an ion trap. Melting points were measured
with a Büchi apparatus B-540 (Büchi, Flawill, Switzerland) and are
reported in °C and are not corrected. Gas chromatography (GC) was
performed on a Varian 3800 gas chromatograph coupled to a
Saturn 2200 ion trap from Varian (Darmstadt, Germany). The auto-
sampler was from CTC Analytics (Zwingen, Switzerland) and the
split/splitless injector was a Varian 1177 (Darmstadt, Germany). In-
strument control and data analysis were carried out with Varian
Workstation 6.9 SP1 software (Darmstadt, Germany). A Varian VF-5-
ms capillary column of 30 m length, 0.25 mm i.d. and 0.25 μm film
thickness (Darmstadt, Germany) was used at a constant flow rate
of 1.4 mL/min. Carrier gas was helium 99.999 % from Air Liquide
(Düsseldorf, Germany). The inlet temperature was kept at 300 °C
and injection volume was 1 μL with splitless time 1.0 min. The initial
column temperature was 50 °C and was held for 1.0 min. Then the
temperature was ramped up to 250 °C with 50 °C/min. Then the
products were eluted at a rate of 5 °C/min until 310 °C (hold time
3 min). Total run time was 20 min. Transfer line temperature was
300 °C and the ion trap temperature was 150 °C. The ion trap was
operated with electron ionization (EI) at 70 eV in scan mode (m/z
50–650) with a solvent delay of 6.3 min.
Crystallography: All X-ray intensity data were measured on a
Bruker D8 Venture TXS system equipped with a multilayer mirror
optics monochromator and a Mo Kα rotating-anode X-ray tube (λ =
0.71073 Å). The data collections were performed at 103 K. The
frames were integrated with the Bruker SAINT Software package.[35]
Data were corrected for absorption effects using the Multi-Scan
method (SADABS).[36] The structures were solved and refined using
the Bruker SHELXTL Software Package.[37] All C-bound hydrogen
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Deposition Number(s) 1907495 (for 8a) contain(s) the supplemen-
tary crystallographic data for this paper. These data are provided
free of charge by the joint Cambridge Crystallographic Data Centre
and Fachinformationszentrum Karlsruhe Access Structures service
www.ccdc.cam.ac.uk/structures.
Synthesis of Compounds
Diazene 2 was synthesised according to a literature protocol[21] in
two steps and a total yield of 81 %.
1-(tert-Butyl) 2-(2,2,2-Trichloroethyl) 1-(2-Methyl-1-oxopropan-
2-yl)hydrazine-1,2-dicarboxylate (6a) and 2-(tert-Butyl) 1-(2,2,2-
Trichloroethyl) 1-(2-Methyl-1-oxopropan-2-yl)hydrazine-1,2-di-
carboxylate (6b): Route A: A suspension of LiOTf (875 mg,
5.61 mmol, 1.52 equiv.) in dry CHCl3 (20 mL) was cooled to - 50 °C.
A solution of diazene 2 (1.70 g, 5.56 mmol, 1.5 equiv.) in CHCl3
(10 mL), 2-methyl-1-(trimethylsilyloxy)-1-propene (3) (533 mg,
3.70 mmol, 1.0 equiv.) in CHCl3 (10 mL) was added, followed by
TBAF (1 M in THF, 3.7 mL, 3.7 mmol, 1.0 equiv.). The resulting reac-
tion mixture was warmed to room temperature and stirred for 16 h.
The reaction was stopped with aq. sat. NH4Cl solution (10 mL) and
the layers were separated. The organic layer was washed with aq.
sat. NaHCO3 solution (10 mL), dried with MgSO4, filtered and the
solvent was removed in vacuo. The title compound was purified by
flash column chromatography (hexanes/EtOAc, 8:1). An inseparable
mixture of aldehydes 6a/6b (911 mg, 2.43 mmol, 66 %) were ob-
tained as a colourless solid in an isomeric mixture of 50:50 (deter-
mined retrospectively via 1H NMR). Route B: Diazene 2 (690 mg,
2.26 mmol, 1.0 equiv.) and (S)-5-(pyrrolidin-2-yl)-1H-tetrazole (5)
(31.4 mg, 0.226 mmol, 10 mol-%) were dissolved in dry dichloro-
methane (15 mL) and the solution was cooled to 0 °C. Isobutyralde-
hyde (4) (0.25 mL, 2.71 mmol, 1.2 equiv.) was added slowly and the
reaction mixture was warmed to room temperature. After comple-
tion of the reaction, the solvent was removed in vacuo and the
product was purified by flash column chromatography (hexanes/
EtOAc, 8:1). An inseparable mixture of aldehydes 6a/6b (580 mg,
1.53 mmol, 68 %) were obtained as a colourless solid in an isomeric
mixture of 91:9 (determined retrospectively via 1H NMR): Rf = 0.17
(hexanes/EtOAc, 8:1); m.p. 128–129 °C; 1H NMR (500 MHz, [D]chloro-
form) δ/ppm = 9.49 (s, 1H), 6.70 (s, 1H), 4.93–4.51 (m, 2H), 1.44 (s,
9H), 1.36 (s, 3H), 1.29 (s, 3H); 13C NMR (101 MHz, [D]chloroform δ/
ppm = 198.1, 155.4, 154.3, 94.9, 84.3, 75.2, 67.4, 28.2, 20.5; IR (ATR)
ν̃ = /cm–1 = 3255, 3013, 2980, 2936, 1771, 1723, 1694, 1528, 1457,
1391, 1380, 1365, 1358, 1287, 1254, 1220, 1161, 1108, 1054, 992,
945, 916, 882, 858, 834, 817, 799, 763, 750, 724, 709, 658; HRMS
(ESI): m/z calcd. for C12H18Cl3N2O5 [M – H]– 375.0287, found
375.0287.
1-(tert-Butyl) 2-(2,2,2-Trichloroethyl) 1-(2-Methylbut-3-en-2-
yl)hydrazine-1,2-di-carboxylate (7a) and 2-(tert-Butyl) 1-(2,2,2-
Trichloroethyl) 1-(2-Methylbut-3-en-2-yl)hydrazine-1,2-dicarb-
oxylate (7b): The isomeric mixture of aldehydes 6a/6b (569 mg,
1.51 mmol, 1.0 equiv.) and pyridine (0.22 mL, 2.7 mmol, 1.8 equiv.)
were added to a flame dried flask and the mixture was blended to
a gel via ultrasound bath. The suspension was cooled to –80 °C and
Tebbe reagent (0.5 M in toluene, 3.92 mL, 1.96 mmol, 1.3 equiv.)
was added carefully by adding it along the flask. The reaction mix-
ture was warmed to 0 °C and stirred 48 h. The reaction was
quenched with a saturated aqueous NaHCO3 solution (6 mL) at
–80 °C and extracted with dichloromethane (3 × 10 mL). The com-
bined organic layers were dried with MgSO4, filtered and the sol-
vent was removed in vacuo. Purification by flash column chroma-
tography (hexanes/EtOAc, 9:1) gave an inseparable mixture of ole-
fins 7a/7b (270 mg, 0.719 mmol, 48 %) as a colourless solid in an
isomeric mixture of 91:9 (determined retrospectively via 1H NMR):
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Rf = 0.29 (hexanes/EtOAc, 9:1); m.p. 103–104 °C; 1H NMR (500 MHz,
[D]chloroform) δ/ppm = 6.68 (s, 1H), 6.10 (dd, 3JH,H = 17.4, 11.0 Hz,
1H), 5.08 (d, 3JH,H = 17.1 Hz, 1H), 5.00 (d, 3JH,H = 10.9 Hz, 1H), 4.87
(d, 2JH,H = 11.5 Hz, 1H), 4.68 (d, 2JH,H = 11.8 Hz, 1H), 1.50 (s, 3H),
1.44 (s, 9H), 1.42 (s, 3H); 13C NMR (126 MHz, [D]chloroform) δ/ppm =
155.4, 154.5, 144.6, 111.2, 95.2, 82.1, 75.1, 62.9, 28.4, 26.6, 26.4; IR
(ATR) ν̃ = /cm–1 = 3323, 2924, 2854, 1733, 1706, 1644, 1522, 1456,
1414, 1386, 1359, 1274, 1253, 1233, 1156, 1101, 1078, 1044, 1011,
990, 967, 922, 907, 851, 815, 759, 741, 724, 688; HRMS (ESI): m/z
calcd. for C13H20O4N2Cl3 [M – H]– 373.0494, found 373.0499.
tert-Butyl 1-(2-Methylbut-3-en-2-yl)hydrazine-1-carboxylate
(8a) and tert-Butyl 2-(2-Methylbut-3-en-2-yl)hydrazine-1-carb-
oxylate (8b): The mixture of olefins 7a/7b (95.6 mg, 0.254 mmol,
1.0 equiv.) was dissolved in a mixture of ethanol (0.3 mL), water
(0.3 mL) and acetic acid (0.3 mL). Zinc powder (582 mg, 8.91 mmol,
35.0 equiv.) was added and the reaction mixture was stirred for 10
minutes at room temperature. After filtration of the reaction mix-
ture, the filtrate was extracted with dichloromethane (3 × 3 mL) and
the residue was extracted. The combined organic layers were
washed was saturated aqueous NaHCO3 solution (5 mL) and the
organic layer was dried with MgSO4, filtered and the solvent was
removed in vacuo. The product was used without purification.
8a/8b (57 mg, 0.28 mmol, quantitative) was obtained as a colour-
less oil in an isomeric mixture of 91:9: Rf = 0.15 (hexanes/EtOAc,
8:2); 1H NMR (8a) (400 MHz, [D6]DMSO) δ/ppm = 6.00 (dd, 3JH,H =
17.5, 10.7 Hz, 1H), 4.87 (dd, 3JH,H = 17.5, 10.8, 2H), 4.24 (s, 2H), 1.38
(s, 9H), 1.33 (s, 6H); 13C NMR (8a) (126 MHz, [D6]DMSO) δ/ppm =
156.4, 146.2, 108.8, 79.3, 60.6, 28.1, 26.5; 1H NMR (8b) (500 MHz,
[D6]DMSO) δ/ppm = 7.95 (s, 1H), 5.81 (dd, 3JH,H = 17.6, 10.8 Hz, 1H),
5.08–4.92 (m, 2H), 4.07 (s, 1H), 1.38 (s, 9H), 1.03 (s, 6H); 13C NMR
(8b) (126 MHz, [D6]DMSO) δ/ppm = 155.6, 145.0, 112.2, 78.1, 57.8,
28.2, 24.8; IR (ATR) ν̃ = /cm–1 = 3334, 2977, 2932, 1679, 1477, 1455,
1412, 1365, 1249, 1163, 1101, 1005, 994, 948, 907, 868, 766, 724,
687; HRMS (ESI): m/z calcd. for C10H21N2O2 [M + H]+ 201.1597, found
201.1597.
General Procedure 1 (GP1) for the Synthesis of N-Boc-N-(1,1-
Dimethylallyl)hydrazones 9a–q: The mixture of N-(1,1-dimethyl-
allyl)hydrazines 8a/8b (1.0 equiv.) was dissolved in absolute EtOH
and the appropriate aldehyde (1.0 equiv.) was added. The reaction
mixture was stirred at room temperature for 15 h, then the solvent
was removed in vacuo and the crude product was purified by flash
column chromatography. Isolated yields are correlated to the
amount of 8a in the isomeric mixture 8a/8b.
tert-Butyl 1-(2-methylbut-3-en-2-yl)-2-octylidenehydrazine-1-
carboxylate (9a): Mixture of allylhydrazines 8a/8b (250 mg,
1.75 mmol  1.59 mmol of isomer 8a) and octanal (0.298 mL,
1.75 mmol) gave N-Boc-N-allylhydrazone 9a (178 mg, 0.576 mmol,
36 % referred to isomer 8a) as colourless oil via GP1: Rf = 0.58
(hexanes/EtOAc, 9:1); 1H NMR (400 MHz, [D]chloroform) δ/ppm =
7.71 (t, 3JH,H = 5.6 Hz, 1H), 6.11 (dd, 3JH,H = 17.5, 10.8 Hz, 1H), 5.07–
4.86 (m, 2H), 2.35 (td, 3JH,H = 5.6 Hz, 2H), 1.59–1.50 (m, 2H), 1.42 (s,
9H), 1.39 (s, 6H), 1.34–1.24 (m, 8H), 0.87 (m, 3H); 13C NMR (101 MHz,
[D]chloroform) δ/ppm = 169.5, 154.3, 146.3, 109.4, 80.9, 61.7, 33.0,
31.9, 29.5, 29.2, 28.6, 26.7, 26.2, 22.8, 14.3; IR (ATR) ν̃ = /cm–1 = 3084,
3004, 2972, 2958, 2927, 2857, 1698, 1641, 1455, 1412, 1391, 1366,
1302, 1244, 1157, 1101, 1003, 991, 901, 855, 757, 724, 686; HRMS
(ESI): m/z calcd. for C18H35N2O2 [M + H]+ 311.2693, found 311.2694.
tert-Butyl 1-(2-Methylbut-3-en-2-yl)-2-nonylidenehydrazine-1-
carboxylate (9b): Mixture of allylhydrazines 8a/8b (404 mg,
2.02 mmol  1.83 mmol of isomer 8a) and nonanal (0.346 mL,
2.02 mmol) gave N-Boc-N-allylhydrazone 9b (284 mg, 0.877 mmol,
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(hexanes/EtOAc, 9:1); 1H NMR (500 MHz, [D]chloroform) δ/ppm =
7.71 (t, 3JH,H = 5.6 Hz, 1H), 6.11 (dd, 3JH,H = 17.5, 10.8 Hz, 1H), 5.05–
4.89 (m, 2H), 2.34 (td, 3JH,H = 5.6 Hz, 2H), 1.55 (m, 2H), 1.42 (s, 9H),
1.39 (s, 6H), 1.36–1.21 (m, 10H), 0.89–0.85 (m, 3H); 13C NMR
(101 MHz, [D]chloroform) δ/ppm = 169.4, 154.3, 146.3, 109.4, 80.9,
61.7, 33.0, 31.9, 29.5, 29.4, 29.3, 28.5, 26.7, 26.2, 22.8, 14.2; IR (ATR)
ν̃ = /cm–1 = 3086, 2972, 2956, 2926, 2856, 1698, 1640, 1455, 1412,
1390, 1366, 1302, 1244, 1157, 1100, 1003, 992, 900, 874, 857, 783,
756, 723, 687, 599; HRMS (ESI): m/z calcd. for C19H37N2O2 [M + H]+
325.2849, found 325.2849.
tert-Butyl 2-Decylidene-1-(2-methylbut-3-en-2-yl)hydrazine-1-
carboxylate (9c): Mixture of allylhydrazines 8a/8b (115 mg,
0.574 mmol  0.522 mmol of isomer 8a) and decanal (0.108 mL,
0.574 mmol) gave N-Boc-N-allylhydrazone 9c (56 mg, 0.17 mmol,
33 % referred to isomer 8a) as colourless oil via GP1: Rf = 0.56
(hexanes/EtOAc, 9:1). 1H NMR (500 MHz, [D]chloroform) δ/ppm =
7.71 (t, 3JH,H = 5.6 Hz, 1H), 6.11 (dd, 3JH,H = 17.5, 10.8 Hz, 1H), 5.01
(dd, 3JH,H = 17.5, 2JH,H = 0.7 Hz, 1H), 4.92 (dd, J 3JH,H = 10.8, 2JH,H =
0.7 Hz, 1H), 2.35 (td, 3JH,H = 5.6 Hz, 2H), 1.57–1.54 (m, 2H), 1.42 (s,
9H), 1.39 (s, 6H), 1.26 (m, 12H), 0.89–0.86 (m, 3H). 13C NMR
(126 MHz, [D]chloroform) δ/ppm = 169.5, 154.3, 146.3, 109.4, 80.9,
61.7, 33.0, 32.0, 29.6, 29.5, 29.5, 29.4, 28.6, 26.7, 26.2, 22.8, 14.3. IR
(ATR) ν̃ = /cm–1 = 2924, 2853, 1696, 1458, 1407, 1368, 1310, 1245,
1158, 1101, 990, 903, 852, 754, 719, 665. HRMS (ESI): m/z calcd. for
C20H39N2O2 [M + H]+ 339.3006, found 339.3011.
tert-Butyl 1-(2-Methylbut-3-en-2-yl)-2-(2-methylpropylidene)-
hydrazine-1-carboxylate (9d): Mixture of olefins 8a/8b (519 mg,
2.59 mmol  2.36 mmol of isomer 8a) and isobutyraldehyde (4)
(0.237 mL, 2.59 mmol) gave N-Boc-N-allylhydrazone 9d (262 mg,
1.03 mmol, 44 % referred to isomer 8a) as colourless oil via GP1:
Rf = 0.55 (hexanes/EtOAc, 9:1); 1H NMR (400 MHz, [D]chloroform) δ/
ppm = 7.61 (d, 3JH,H = 5.9 Hz, 1H), 6.11 (dd, 3JH,H = 17.6, 10.8 Hz,
1H), 5.03–4.90 (m, 2H), 2.66–2.56 (m, 1H), 1.42 (s, 9H), 1.39 (s, 6H),
1.13 (s, 3H), 1.12 (s, 3H). 13C NMR (101 MHz, [D]chloroform) δ/ppm =
173.2, 154.1, 146.3, 109.4, 80.9, 61.9, 32.2, 28.6, 26.6, 19.6. IR (ATR)
ν̃ = /cm–1 = 3086, 3008, 2973, 2930, 2872, 1698, 1641, 1456, 1412,
1390, 1366, 1304, 1289, 1244, 1156, 1092, 1058, 992, 970, 902, 879,
856, 756, 686, 599, 588. HRMS (ESI): m/z calcd. for C14H27N2O2 [M +
H]+ 255.2067, found 255.2066.
tert-Butyl 2-(2-Ethoxy-2-oxoethylidene)-1-(2-methylbut-3-en-2-
yl)hydrazine-1-carboxylate (9e): Mixture of olefins 8a/8b
(200 mg, 0.990 mmol,  0.901 mmol of isomer 8a) and ethyl glyox-
alate solution (ca. 50 % in toluene, 0.198 mL, 0.990 mmol) gave N-
Boc-N-allylhydrazone 9e (108 mg, 0.380 mmol, 42 % referred to iso-
mer 8a) as colourless oil via GP1: Rf = 0.44 (hexanes/EtOAc, 9:1); 1H
NMR (400 MHz, [D]chloroform) δ/ppm = 8.41 (s, 1H), 6.05 (dd,
3JH,H = 17.5, 10.8 Hz, 1H), 5.07–4.93 (m, 2H), 4.26 (q, 3JH,H = 7.1 Hz,
2H), 1.52 (s, 6H), 1.48 (s, 9H), 1.31 (t, 3JH,H = 7.1 Hz, 3H); 13C NMR
(101 MHz, [D]chloroform) δ/ppm = 164.9, 151.9, 145.5, 135.7, 110.6,
83.6, 65.9, 60.9, 28.3, 27.7, 14.4; IR (ATR) ν̃ = /cm–1 = 1742, 1708,
1585, 1477, 1456, 1369, 1339, 1288, 1242, 1206, 1181, 1148, 1113,
1093, 1044, 911, 848, 798, 759, 744, 576; HRMS (EI): m/z calcd. for
C9H16N2O2 [M – Boc]̇+ 184.1206, found 184.1205.
tert-Butyl 2-(Cyclopentylmethylene)-1-(2-methylbut-3-en-2-yl)-
hydrazine-1-carboxylate (9f): Mixture of olefins 8a/8b. (430 mg,
2.15 mmol  1.96 mmol of isomer 8a) and cyclopentane carboxal-
dehyde (0.229 mL, 2.15 mmol) gave N-Boc-N-allylhydrazone 9f
(245 mg, 0.874 mmol, 45 % referred to isomer 8a) as colourless oil
via GP1: Rf = 0.57 (hexanes/EtOAc, 9:1); 1H NMR (400 MHz, [D]chloro-
form) δ/ppm = 7.62 (d, 3JH,H = 6.8 Hz, 1H), 6.11 (dd, 3JH,H = 17.5,
10.8 Hz, 1H), 5.08–4.82 (m, 2H), 2.87–2.71 (m, 1H), 1.95–1.79 (m, 2H),
1.73–1.54 (m, 6H), 1.42 (s, 9H), 1.38 (s, 6H); 13C NMR (101 MHz,
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[D]chloroform) δ/ppm = 172.6, 154.2, 146.2, 109.4, 80.8, 61.8, 42.9,
30.3, 28.6, 28.5, 26.6, 25.7; IR (ATR) ν̃ = /cm–1 = 3084, 2968, 2956,
2869, 1697, 1639, 1476, 1454, 1412, 1390, 1366, 1304, 1244, 1156,
1101, 1061, 1003, 992, 900, 877, 856, 783, 757, 687; HRMS (ESI): m/z
calcd. for C16H29N2O2 [M + H]+ 281.2224, found 281.2225.
tert-Butyl 2-(Cyclohexylmethylene)-1-(2-methylbut-3-en-2-yl)-
hydrazine-1-carboxylate (9g): Mixture of olefins 8a/8b (91.6 mg,
0.686 mmol  0.624 mmol of isomer 8a) and cyclohexanecarbox-
aldehyde (55.4 μL, 0.686 mmol) gave N-Boc-N-allylhydrazone 9f
(63.3 mg, 0.215 mmol, 34 % referred to isomer 8a) as colourless oil
via GP1: Rf = 0.64 (hexanes/EtOAc, 9:1); 1H NMR (500 MHz, [D]chloro-
form) δ/ppm = 7.58 (d, 3JH,H = 6.0 Hz, 1H), 6.11 (dd, 3JH,H = 17.5,
10.8 Hz, 1H), 5.01 (dd, 3JH,H = 17.5, 2JH,H = 0.9 Hz, 1H), 4.92 (dd,
3JH,H = 10.8, 2JH,H = 0.9 Hz, 1H), 2.42–2.25 (m, 1H), 1.89–1.80 (m, 2H),
1.80–1.73 (m, 2H), 1.70–1.64 (m, 1H), 1.41 (s, 9H), 1.39 (s, 6H), 1.35–
1.28 (m, 4H), 1.27–1.18 (m, 1H). 13C NMR (101 MHz, [D]chloroform)
δ/ppm = 172.6, 154.3, 146.3, 109.4, 80.8, 61.8, 41.5, 29.9, 28.6, 26.7,
26.1, 25.5; IR (ATR) ν̃ = /cm–1 = 2929, 2854, 1709, 1366, 1308, 1244,
1160; HRMS (ESI): m/z calcd. for C17H31N2O2: 295.2380 [M + H]+,
found 295.2385.
tert-Butyl 2-(Cyclohex-1-en-1-ylmethylene)-1-(2-methylbut-3-
en-2-yl)hydrazine-1-carboxylate (9h): Mixture of olefins 8a/8b
(200 mg, 0.999 mmol  0.909 mmol of isomer 8a) and 1-cyclohex-
ene-1-carboxaldehyde (0.114 mL, 0.990 mmol) gave N-Boc-N-allyl-
hydrazone 9h (135 mg, 0.460 mmol, 51 % referred to isomer 8a) as
colourless oil via GP1: Rf = 0.52 (hexanes/EtOAc, 9:1); 1H NMR
(400 MHz, [D]chloroform) δ/ppm = 7.99 (s, 1H), 6.18–6.05 (m, 2H),
5.05–4.85 (m, 2H), 2.37–2.12 (m, 4H), 1.70–1.61 (m, 4H), 1.43 (s, 9H),
1.41 (s, 6H); 13C NMR (101 MHz, [D]chloroform) δ/ppm = 163.9,
153.9, 146.6, 138.2, 136.3, 109.1, 81.2, 62.7, 28.6, 26.9, 26.3, 23.4,
22.5, 22.1; IR (ATR) ν̃ = /cm–1 = 2976, 2931, 2859, 1697, 1639, 1596,
1366, 1291, 1243, 1152, 1107, 902, 881, 754, 699; HRMS (ESI): m/z
calcd. for C17H29N2O2 [M + H]+ 293.2224, found 293.2223.
tert-Butyl 2-Benzylidene-1-(2-methylbut-3-en-2-yl)hydrazine-1-
carboxylate (9i): Mixture of olefins 8a/8b (580 mg, 2.90 mmol 
2.64 mmol of isomer 8a) and benzaldehyde (0.294 mL, 2.90 mmol)
gave N-Boc-N-allylhydrazone 9i (312 mg, 1.08 mmol, 41 % referred
to isomer 8a) as colourless oil via GP1: Rf = 0.64 (hexanes/EtOAc,
9:1); 1H NMR (400 MHz, [D]chloroform) δ/ppm = 8.65 (s, 1H), 7.74–
7.68 (m, 2H), 7.43–7.34 (m, 3H), 6.17 (dd, 3JH,H = 17.5, 10.8 Hz, 1H),
5.11–4.90 (m, 2H), 1.52 (s, 6H), 1.47 (s, 9H); 13C NMR (101 MHz,
[D]chloroform) δ/ppm = 157.1, 153.6, 146.4, 135.4, 130.2, 128.7,
127.7, 109.4, 81.8, 63.6, 28.5, 27.2; IR (ATR) ν̃ = /cm–1 = 3083, 3062,
2976, 2932, 1697, 1642, 1574, 1476, 1449, 1412, 1391, 1366, 1289,
1243, 1149, 1109, 1071, 992, 947, 898, 856, 784, 753, 692, 659, 563;
HRMS (ESI): m/z calcd. for C17H25N2O2 [M + H]+ 289.1910, found
289.1909.
tert-Butyl 2-(4-Bromobenzylidene)-1-(2-methylbut-3-en-2-yl)-
hydrazine-1-carboxylate (9j): Mixture of olefins 8a/8b (243 mg,
1.21 mmol  1.10 mmol of isomer 8a) and 4-bromobenzaldehyde
(224 mg, 1.21 mmol) gave N-Boc-N-allylhydrazone 9j (356 mg,
0.971 mmol, 88 % referred to isomer 8a) as colourless oil via GP1:
Rf = 0.64 (hexanes/EtOAc, 9:1); 1H NMR (500 MHz, [D]chloroform) δ/
ppm = 8.68 (s, 1H), 7.56 (d, 3JH,H = 8.4 Hz, 2H), 7.50 (d, 3JH,H = 8.3 Hz,
2H), 6.14 (dd, 3JH,H = 17.5, 10.8 Hz, 1H), 5.07–4.92 (m, 2H), 1.51 (s,
6H), 1.47 (s, 9H); 13C NMR (126 MHz, [D]chloroform) δ/ppm = 153.9,
153.5, 146.3, 134.7, 131.9, 128.9, 124.1, 109.6, 82.1, 63.9, 28.5, 27.3;
IR (ATR) ν̃ = /cm–1 = 3086, 2979, 2932, 1696, 1643, 1591, 1564, 1487,
1455, 1412, 1392, 1367, 1289, 1244, 1148, 1115, 1098, 1069, 1044,
1009, 992, 953, 929, 901, 856, 819, 786, 752, 708, 691, 667; HRMS
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tert-Butyl 2-(4-(Dimethylamino)benzylidene)-1-(2-methylbut-3-
en-2-yl)hydrazine-1-carboxylate (9k): Mixture of olefins 8a/8b
(100 mg, 0.499 mmol  0.454 mmol of isomer 8a) and 4-dimethyl-
aminobenzaldehyde (74.5 mg, 0.499 mmol) gave N-Boc-N-allyl-
hydrazone 9k (143 mg, 0.431 mmol, 95 % referred to isomer 8a) as
white crystalline solid via GP1: Rf = 0.35 (hexanes/EtOAc, 9:1); m.p.
73–75 °C; 1H NMR (400 MHz, [D]chloroform) δ/ppm = 8.30 (s, 1H),
7.61 (d, 3JH,H = 8.9 Hz, 2H), 6.69 (d, 3JH,H = 8.9 Hz, 2H), 6.19 (dd,
3JH,H = 17.5, 10.8 Hz, 1H), 5.08–4.90 (m, 2H), 3.01 (s, 6H), 1.47 (s, 6H),
1.44 (s, 9H); 13C NMR (101 MHz, [D]chloroform) δ/ppm = 162.4,
154.2, 152.2, 146.6, 129.4, 122.4, 111.8, 109.2, 80.9, 62.6, 40.4, 28.6,
26.9; IR (ATR) ν̃ = /cm–1 = 2976, 2930, 1693, 1616, 1601, 1528, 1477,
1455, 1363, 1300, 1237, 1155, 1100, 1060, 894, 859, 816, 755, 731;
HRMS (ESI): m/z calcd. for C19H30N3O2 [M + H]+ 332.2333, found
332.2333.
tert-Butyl 2-(4-Methoxybenzylidene)-1-(2-methylbut-3-en-2-yl)-
hydrazine-1-carboxylate (9l): Mixture of olefins 8a/8b (150 mg,
0.749 mmol  0.682 mmol of isomer 8a) and 4-anisaldehyde
(102 mg, 91.1 μL, 0.749 mmol) gave N-Boc-N-allylhydrazone 9l
(151 mg, 0.475 mmol, 70 % referred to isomer 8a) as colourless oil
via GP1: Rf = 0.42 (hexanes/EtOAc, 9:1); 1H NMR (400 MHz, [D]chloro-
form) δ/ppm = 8.48 (s, 1H), 7.66 (d, 3JH,H = 8.8 Hz, 2H), 6.91 (d,
3JH,H = 8.9 Hz, 2H), 6.17 (dd, 3JH,H = 17.5, 10.8 Hz, 1H), 5.08–4.92
(m, 2H), 3.84 (s, 3H), 1.49 (s, 6H), 1.45 (s, 9H); 13C NMR (101 MHz,
[D]chloroform) δ/ppm = 161.5, 159.0, 153.9, 146.5, 129.3, 127.8,
114.1, 109.3, 81.4, 63.1, 55.5, 28.6, 27.0; IR (ATR) ν̃ = /cm–1 = 2975,
2932, 1693, 1606, 1512, 1456, 1366, 1293, 1245, 1150, 1104, 1031,
900, 859, 831, 75; HRMS (ESI): m/z calcd. for C18H27N2O3 [M + H]+
319.2016, found 319.2015.
tert-Butyl 1-(2-Methylbut-3-en-2-yl)-2-(4-nitrobenzylidene)-
hydrazine-1-carboxylate (9m): Mixture of olefins 8a/8b (250 mg,
1.25 mmol  1.14 mmol of isomer 8a) and 4-nitrobenzaldehyde
(0.126 mL, 1.25 mmol) gave N-Boc-N-allylhydrazone 9m (233 mg,
0.698 mmol, 61 % referred to isomer 8a) as yellow solid via GP1:
Rf = 0.51 (hexanes/EtOAc, 9:1); m.p. 67–69 °C; 1H NMR (400 MHz,
[D]chloroform) δ/ppm = 9.02 (s, 1H), 8.24–8.19 (m, 2H), 7.82–7.75
(m, 2H), 6.12 (dd, J = 17.5, 10.8 Hz, 1H), 5.10–4.93 (m, 2H), 1.56 (s,
6H), 1.50 (s, 9H); 13C NMR (101 MHz, [D]chloroform) δ/ppm = 152.9,
148.1, 147.7, 145.9, 142.7, 127.6, 124.0, 110.1, 82.9, 65.0, 28.5, 27.6;
IR (ATR) ν̃ = /cm–1 = 1699, 1598, 1572, 1518, 1368, 1343, 1286, 1246,
1146, 1107, 907, 849, 832, 729, 692, 647; HRMS (EI): m/z calcd. for
C17H23N3O4 [M]̇+ 333.1683, found 333.1710.
tert-Butyl 1-(2-Methylbut-3-en-2-yl)-2-(thiophen-2-ylmethyl-
ene)hydrazine-1-carboxylate (9n): Mixture of olefins 8a/8b
(150 mg, 0.749 mmol  0.681 mmol of isomer 8a) and 2-thiophene-
carboxaldehyde (70 μL, 0.749 mmol) gave N-Boc-N-allylhydrazone
9n (104 mg, 0.352 mmol, 52 % referred to isomer 8a) as light yellow
oil via GP1: Rf = 0.60 (hexanes/EtOAc, 9:1); 1H NMR (400 MHz,
[D]chloroform) δ/ppm = 8.85–8.83 (m, 1H), 7.32 (dt, 3JH,H = 5.0,
1.0 Hz, 1H), 7.24 (dd, 3JH,H = 3.6, 1.2 Hz, 1H), 7.04 (dd, 3JH,H = 5.1,
3.6 Hz, 1H), 6.14 (dd, 3JH,H = 17.5, 10.8 Hz, 1H), 5.08–4.91 (m, 2H),
1.49 (s, 6H), 1.47 (s, 9H); 13C NMR (101 MHz, [D]chloroform) δ/ppm =
153.6, 150.2, 146.3, 140.9, 129.7, 127.9, 127.4, 109.5, 81.9, 63.7, 28.5,
27.2; IR (ATR) ν̃ = /cm–1 = 2985, 2938, 1742, 1708, 1585, 1369, 128,
1242, 1181, 1148, 1113, 1093, 1044, 911, 848, 759, 744, 576; HRMS
(EI): m/z calcd. for C15H22N2O2S [M]̇+ 294.1396, found 294.1392.
tert-Butyl 1-(2-Methylbut-3-en-2-yl)-2-(pyridin-4-ylmethylene)-
hydrazine-1-carboxylate (9o): Mixture of olefins 8a/8b (350 mg,
1.75 mmol  1.59 mmol of isomer 8a) and 4-pyridinecarboxalde-
hyde (0.165 mL, 1.75 mmol) gave N-Boc-N-allylhydrazone 9o
(342 mg, 1.18 mmol, 74 % referred to isomer 8a) as light yellow oil
via GP1: Rf = 0.12 (hexanes/EtOAc, 9:1); 1H NMR (400 MHz, [D]chloro-
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form) δ/ppm = 8.90 (s, 1H), 8.65–8.55 (m, 2H), 7.50 (dd, 3JH,H = 6.1,
0.4 Hz, 2H), 6.11 (dd, 3JH,H = 17.5, 10.8 Hz, 1H), 5.11–4.90 (m, 2H),
1.54 (s, 6H), 1.49 (s, 9H); 13C NMR (101 MHz, [D]chloroform) δ/ppm =
152.9, 150.3, 147.7, 146.0, 143.8, 121.1, 109.9, 82.8, 64.9, 28.5, 27.6;
IR (ATR) ν̃ = /cm–1 = 2977, 2933, 1698, 1590, 1367, 1287, 1246,
1147, 989, 903, 859, 814, 755, 732, 656; HRMS (ESI): m/z calcd. for
C16H24N3O2 [M + H]+ 290.1863, found 290.1862.
tert-Butyl 1-(2-Methylbut-3-en-2-yl)-2-(3-phenylpropylidene)-
hydrazine-1-carboxylate (9p): Mixture of olefins 8a/8b (237 mg,
1.18 mmol  1.07 mmol of isomer 8a) and 3-phenylpropionalde-
hyde (0.157 mL, 1.18 mmol) gave N-Boc-N-allylhydrazone 9p
(141 mg, 0.446 mmol, 42 % referred to isomer 8a) as colourless oil
via GP1: Rf = 0.46 (hexanes/EtOAc, 9:1); 1H NMR (400 MHz,
[D6]DMSO) δ/ppm = 7.75 (t, 3JH,H = 5.3 Hz, 1H), 7.31–7.22 (m, 4H),
7.18 (m, 1H), 5.99 (dd, 3JH,H = 17.5, 10.8 Hz, 1H), 4.94 (dd, 3JH,H =
17.5, 2JH,H = 1.1 Hz, 1H), 4.86 (dd, 3JH,H = 10.8, 2JH,H = 1.1 Hz, 1H),
2.83 (t, 3JH,H = 7.3 Hz, 2H), 2.59 (ddd, 3JH,H = 7.3, 5.3 Hz, 2H),1.36 (s,
9H), 1.25 (s, 6H); 13C NMR (101 MHz, [D6]DMSO) δ/ppm = 166.7,
153.2, 145.7, 140.9, 128.3, 128.3, 125.9, 109.4, 80.1, 61.1, 33.9, 31.3,
27.9, 26.4; IR (ATR) ν̃ = /cm–1 = 2979, 2929, 1693, 1639, 1455, 1264,
1303, 1241, 1155, 1101, 903, 870, 856, 748; HRMS (ESI): m/z calcd.
for C19H29N2O2 [M + H]+ 317.2224, found 317.2229.
tert-Butyl 1-(2-Methylbut-3-en-2-yl)-2-((E)-3-phenylallylidene)-
hydrazine-1-carboxylate (9q): Mixture of olefins 8a/8b (250 mg,
1.25 mmol  1.13 mmol of isomer 8a) and cinnamaldehyde
(0.157 mL, 1.25 mmol) gave N-Boc-N-allylhydrazone 9q (228 mg,
0.725 mmol, 64 % referred to isomer 8a) as yellow oil via GP1:
Rf = 0.56 (hexanes/EtOAc, 9:1); 1H NMR (500 MHz, [D]chloroform) δ/
ppm = 8.33 (dd, 3JH,H = 7.2, 1.5 Hz, 1H), 7.49–7.47 (m, 2H), 7.38–
7.33 (m, 2H), 7.32–7.28 (m, 1H), 6.96–6.93 (m, 2H), 6.14 (dd, 3JH,H =
17.5, 10.8 Hz, 1H), 5.07–4.92 (m, 2H), 1.47 (s, 6H), 1.46 (s, 9H); 13C
NMR (101 MHz, [D]chloroform) δ/ppm = 161.7, 153.7, 146.2, 140.5,
136.2, 128.9, 128.9, 127.2, 126.0, 109.5, 81.6, 62.9, 28.5, 26.9; IR (ATR)
ν̃ = /cm–1 = 1694, 1449, 1366, 1289, 1243, 1148, 1109, 1051, 973,
906, 879, 850, 749, 689; HRMS (ESI): m/z calcd. for C19H27N2O2 [M +
H]+ 315.2067, found 315.2066.
General Procedure for the Synthesis of Olefins via [3,3]-Sigma-
tropic Rearrangement (GP2): In an oven dried two-necked
Schlenk flask HNTf2 (10 mol-%) was dissolved in dry diglyme (1 mL).
A solution of the appropriate N-Boc-N-allylhydrazone 9 (1.0 equiv.)
in dry diglyme (2 mL + 1 mL rinse) was added at room temperature.
The reaction mixture was fitted with a N2 flashed reflux condenser
and immediately heated to 125 °C in a pre-heated oil bath. After
completion of the rearrangement detected by TLC (75 min), the
reaction was immediately cooled to room temperature via water
bath and then quenched with a sat. aq. NaHCO3 solution (4 mL).
Pentane (10 mL) was added and the organic layer was washed with
at least 100 mL water. The solvent was removed in vacuo (30 °C,
max. 700 mbar) and the crude product was purified by flash column
chromatography.
2-Methyldodec-2-ene (10a): Allylhydrazone 9a (155 mg,
0.500 mmol) and HNTf2 (14 mg, 0.050 mmol) gave olefin 10a
(18 mg, 0.099 mmol, 20 %) as colourless oil via GP2: Rf = 0.94 (pent-
ane); 1H NMR (400 MHz, [D]chloroform) δ/ppm = 5.15–5.08 (m, 1H),
1.96 (q, 3JH,H = 7.1 Hz, 2H), 1.69 (d, 3JH,H = 1.4 Hz, 3H), 1.60 (d, 3JH,H =
1.3 Hz, 3H), 1.26 (s, 14H), 0.88 (t, 3JH,H = 2.9 Hz, 3H). 13C NMR
(101 MHz, [D]chloroform) δ/ppm = 131.3, 125.1, 32.1, 30.1, 29.8,
29.8, 29.5, 29.5, 28.2, 25.9, 22.9, 17.8, 14.3. IR (ATR) ν̃ = /cm–1 = 2956,
2922, 2853, 1462, 1376, 1094, 985, 886, 833, 722; HRMS (EI): m/z
calcd. for C13H26 [M]̇+ 182.2029, found 182.2027.
2-Methyltridec-2-ene (10b): Allylhydrazone 9b (162 mg,




European Journal of Organic Chemistry
(19 mg, 0.10 mmol, 21 %) as colourless oil via GP2: Rf = 0.88 (pent-
ane/Et2O, 9:1); 1H NMR (400 MHz, [D]chloroform) δ/ppm = 5.12 (tdt,
3JH,H = 7.2, 1.5 Hz, 1H), 1.96 (q, 3JH,H = 6.8 Hz, 2H), 1.69 (d, 3JH,H =
1.4 Hz, 3H), 1.60 (d, 3JH,H = 1.3 Hz, 3H), 1.26 (s, 16H), 0.93–0.83 (m,
3H); 13C NMR (101 MHz, [D]chloroform) δ/ppm = 131.3, 125.1, 32.1,
30.1, 29.8, 29.8, 29.8, 29.5, 29.5, 28.2, 25.9, 22.9, 17.8, 14.3; IR (ATR)
ν̃ = /cm–1 = 2955, 2922, 2853, 1456, 1376, 1094, 984, 886, 832,
721, 593, 556; HRMS (EI): m/z calcd. for C14H28 [M]̇+ 196.2185, found
196.2183.
2-Methyltetradec-2-ene (10c): Allylhydrazone 9c (169 mg,
0.500 mmol) and HNTf2 (14 mg, 0.050 mmol) gave olefin 10c
(21 mg, 0.099 mmol, 20 %) as colourless oil via GP2: Rf = 0.98 (pent-
ane); 1H NMR (400 MHz, [D]chloroform) δ/ppm = 5.12 (ddt, 3JH,H =
7.1 Hz, 1H), 1.96 (q, 3JH,H = 6.9 Hz, 2H), 1.69 (s, 3H), 1.60 (s, 3H), 1.26
(br, 18H), 0.88 (t, 3JH,H = 6.8 Hz, 3H); 13C NMR (101 MHz, [D]chloro-
form) δ/ppm = 131.3, 125.1, 34.3, 32.1, 30.1, 29.9, 29.8, 29.8, 29.5,
28.2, 25.9, 22.9, 22.5, 17.8, 14.3; IR (ATR) ν̃ = /cm–1 = 2958, 2921,
2850, 1461, 1372, 1260, 1090, 1022, 881, 806, 723; HRMS (EI): m/z
calcd. for C15H30 [M]̇+ 210.2342, found 210.2347.
(4-Methylpent-3-en-1-yl)cyclopentane (10f): Allylhydrazone 9f
(140 mg, 0.500 mmol) and HNTf2 (14 mg, 0.050 mmol) gave olefin
10f (15 mg, 0.099 mmol, 20 %) as colourless oil via GP2: Rf = 0.95
(pentane); 1H NMR (500 MHz, [D]chloroform) δ/ppm = 5.15–5.10 (m,
1H), 2.01–1.95 (m, 2H), 1.77–1.73 (m, 2H), 1.69 (d, 3JH,H = 1.4 Hz,
3H), 1.60 (d, 3JH,H = 1.2 Hz, 3H), 1.52–1.46 (m, 2H), 1.34–1.30 (m,
2H), 1.11–1.05 (m, 2H), 0.91–0.86 (m, 3H); 13C NMR (126 MHz,
[D]chloroform) δ/ppm = 131.1, 125.2, 39.9, 36.6, 32.8, 27.4, 25.9,
25.4, 17.8; IR (ATR) ν̃ = /cm–1 = 2983, 2950, 2922, 2857, 1452, 1376,
1105, 985, 907, 830, 735, 650, 574, 560; HRMS (EI): m/z calcd. for
C11H20 [M]̇+ 152.1559, found 152.1558.
(4-Methylpent-3-en-1-yl)cyclohexane (10g): Allylhydrazone 9g
(147 mg, 0.500 mmol) and HNTf2 (14 mg, 0.050 mmol) gave olefin
10g (17 mg, 0.10 mmol, 20 %) as colourless oil via GP2. (4-Methyl-
pent-3-en-1-yl)cyclohexane (10g, 30 mol-% HNTf2). Allyl-
hydrazone 9g (127 mg, 0.433 mmol) and HNTf2 (37 mg, 0.13 mmol)
gave olefin 10g (18 mg, 0.11 mmol, 22 %) as colourless oil via GP2.
(4-Methylpent-3-en-1-yl)cyclohexane (10g, 3.00 mmol scale).
Allylhydrazone 9g (822 mg, 3.00 mmol) and HNTf2 (84 mg,
0.30 mmol) gave olefin 10g (129 mg, 0.759 mmol, 25 %) as colour-
less oil via GP2: Rf = 0.91 (pentane); 1H NMR (500 MHz, [D]chloro-
form) δ/ppm = 5.15–5.00 (m, 1H), 2.03–1.91 (m, 2H), 1.75–1.57 (m,
11H), 1.25–1.15 (m, 6H), 0.92–0.83 (m, 2H); 13C NMR (126 MHz,
[D]chloroform) δ/ppm = 131.1, 125.3, 37.8, 37.5, 33.5, 26.9, 26.6,
25.9, 25.5, 17.8; IR (ATR) ν̃ = /cm–1 = 2923, 2852, 1694, 1448, 1376;
HRMS (EI): m/z calcd. for C12H22 [M]̇+ 166.1722, found 166.1720.
(6-Methylhept-5-en-1-yl)benzene (10p): Allylhydrazone 9p
(217 mg, 0.686 mmol) and HNTf2 (14 mg, 0.068 mmol) gave olefin
10p (25 mg, 0.13 mmol, 19 %) as colourless oil via GP2: Rf = 0.48
(pentane); 1H NMR (400 MHz, dichloromethane-d2) δ/ppm = 7.29–
7.23 (m, 2H), 7.20–7.13 (m, 3H), 5.12 (tdt, 3JH,H = 7.2, 1.5 Hz, 1H),
2.60 (t, 3JH,H = 7.7 Hz, 2H), 2.01 (q, 3JH,H = 7.3 Hz, 2H), 1.68 (d, 3JH,H =
1.4 Hz, 3H), 1.64–1.58 (m, 5H), 1.41–1.33 (m, 2H); 13C NMR (101 MHz,
dichloromethane-d2) δ/ppm = 143.6, 131.8, 128.9, 128.7, 126.1,
125.2, 36.4, 31.8, 30.1, 28.4, 25.9, 17.9; IR (ATR) ν̃ = /cm–1 = 3026,
2922, 2853, 1602, 1494, 1451, 1378, 1108, 1079, 1029, 741, 698, 571;
HRMS (EI): m/z calcd. for C14H20 [M]̇+ 188.1565, found 188.1565.
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